JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harvey, S. C.
Right arrow Articles by Pieper, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harvey, S. C.
Right arrow Articles by Pieper, G. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 114, Issue 1, 14-27, 1955
Copyright © 1955 by American Society for Pharmacology and Experimental Therapeutics


INTRACELLULAR DISTRIBUTION OF DIGITOXIN-C14 IN THE HEART

Stewart C. Harvey 1 and George R. Pieper 1

1 Department of Pharmacology, University of Utah College of Medicine, Salt Lake City, Utah

Isolated guinea pig hearts were perfused with digitoxin-C14. The treated hearts were differentially centrifuged into contaminated-nuclear, debris, mitochondria and aqueous fractions.

The greatest amount of radioactivity was found in the aqueous fraction; however, at 37°C. most of this activity was in the intravascular space. When the vascular space was washed free of radioactive perfusion medium, the debris fraction contained the greatest and the nuclear fraction the second greatest amount of radioactivity. Under these conditions the mitochondria and aqueous fractions each contained less than one-fourth as much as the debris fraction. The highest concentration of radioactivity was found in the debris fraction and the least concentration in the aqueous fraction. The radioactivity in the nuclear fraction was not in the nuclei but rather in the contaminating debris. Any alteration in the calcium or potassium content of the perfusion medium tended to reduce the radioactivity in the particulate fractions and to elevate that in the aqueous fractions.

Calcium excess decreased, whereas calcium deficiency and potassium deficiency increased, the potency of digitoxin when amplitude rather than rhythm was employed as the dependent variable. Changes in uptake and distribution of radiodigitoxin in the nuclear fraction correlated best with changes in potency induced by alterations in calcium concentration.

At both 34° and 40°C. the uptake of radioactivity was higher than at 37°C. The greatest percentage increase occurred in the aqueous fraction, but the highest concentration remained in the debris fraction.

At both 34° and 40°C. the potency of digitoxin was higher than at 37°C. There is a correlation between potency and uptake in the several fractions, except the nuclear fraction; therefore, the correlation indicated above is difficult of interpretation.

At 37°C. the digitoxin (radioactivity) space is only slightly larger than the intravascular space and much smaller than the chloride space. Therefore, very little digitoxin must remain in the interstitial and cytoplasmic fluids. Alterations in cation composition of the medium and in temperature increase the amount of radioactivity in these fluid compartments. From these findings a transcapillary regulation of digitoxin uptake is proposed.

Submitted on January 7, 1955




This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. E. DOHERTY, W. H. PERKINS, and G. K. MITCHELL
Tritiated Digoxin Studies in Human Subjects
Arch Intern Med, October 1, 1961; 108(4): 531 - 539.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1955 by the American Society for Pharmacology and Experimental Therapeutics.